Could Umbilical Cord Blood Help Support Movement?
For children with cerebral palsy, everyday movements such as sitting, standing, and walking can require extra effort. Cerebral palsy affects how the brain controls movement and posture, making physical therapy and other supportive treatments an important part of daily life.
Researchers are now exploring whether umbilical cord blood (UCB) could offer additional support. A 2025 research analysis published in Pediatrics brought together findings from multiple human studies to better understand whether cord blood treatment may help improve movement in children with cerebral palsy.
A Closer Look at the Research
Rather than conducting a new clinical trial, researchers combined individual participant data from 11 previous studies, representing 498 participant records from 447 unique individuals.
The main analysis compared 170 participants who received umbilical cord blood with 171 participants in control groups. Researchers focused on three important questions:
- Did children show improvements in movement?
- Did the number of cells administered affect the results?
- Were certain children more likely to benefit?
To measure progress, researchers used the Gross Motor Function Measure (GMFM-66), a standardized assessment of physical abilities such as rolling, sitting, standing, and walking.
Encouraging Improvements in Motor Function
The analysis found that children receiving umbilical cord blood showed significantly greater improvements in motor function than those in the control groups.
On average, the cord blood group scored:
- 1.36 points higher on the GMFM-66 at six months
- 1.42 points higher at 12 months
While these average differences may sound small, they suggest that cord blood treatment could provide an additional benefit for some children. The improvements were most apparent at six and 12 months, highlighting the importance of allowing time to evaluate potential changes.
Did Age and Cell Dose Make a Difference?
One of the most interesting findings was that not every child appeared to respond in the same way. Children who were younger, particularly those around five years old or younger, tended to show greater improvements. The researchers also found more encouraging results among children with milder forms of cerebral palsy.
Cell dose appeared to matter as well. Higher doses of umbilical cord blood cells were associated with greater improvements in motor function, especially at the three- and 12-month follow-ups.
These findings may help researchers better understand which patients could benefit most and how future treatments might be designed.
Why Is Umbilical Cord Blood Being Studied?
Umbilical cord blood contains several types of cells involved in blood formation and immune function. Researchers believe some of these cells may release signals that help regulate inflammation and support the body’s natural repair processes.
In cerebral palsy research, scientists are particularly interested in whether these effects could help create a healthier environment for the brain and support its ability to form and strengthen connections.
This remains a proposed explanation rather than a proven mechanism, but it offers an interesting direction for regenerative medicine research.
Looking Ahead: A More Personalized Approach
The findings suggest that umbilical cord blood may offer modest but meaningful improvements in motor function for some children with cerebral palsy, particularly younger children with milder symptoms.
However, the studies varied in their treatment methods and participant characteristics, and the analysis could not establish benefits for areas such as communication or cognition. Larger, carefully designed clinical trials are still needed to confirm the findings and determine the best treatment approaches.
What makes this research especially encouraging is its focus on understanding who may benefit most. As regenerative medicine continues to develop, studies like this may help researchers move toward more targeted approaches that support movement and quality of life for children with cerebral palsy.
Source
Finch-Edmondson M, Paton MCB, Webb A, et al. Cord Blood Treatment for Children With Cerebral Palsy: Individual Participant Data Meta-Analysis. Pediatrics. 2025;155(5). doi: 10.1542/peds.2024-068999. Available from: https://publications.aap.org/pediatrics/article/155/5/e2024068999/201565/
Related Treatment Pages